ena-STUDY-Department of Gynecology and Obstetrics, University Hospital of Essen, Germany-18-12-2018-08:07:39:410-180
cfDNA variants of CTC-depleted blood compared to whole blood in metastatic breast cancer patients
We compared cfDNA variants from whole blood of metastatic hormone receptor positive, HER2 negative breast cancer patients with cfDNA variants from matched CTC-depleted blood.
We compared cfDNA variants from whole blood of metastatic hormone receptor positive, HER2 negative breast cancer patients with cfDNA variants from matched CTC-depleted blood.